Northwire Canada EditionWednesday, July 29, 2026
Northwire
NAM 0.250 +0.0% CRD 0.065 +8.3% OLA 12.90 −3.7% CG 22.70 −2.5% EQX 12.89 −4.0% FM 37.51 −2.3% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0% NAM 0.250 +0.0% CRD 0.065 +8.3% OLA 12.90 −3.7% CG 22.70 −2.5% EQX 12.89 −4.0% FM 37.51 −2.3% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0%
Other

AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart-Brain Connection

AIML · Price

Executive Summary

  • AI/ML Innovations Inc. (AIML) announced a pilot project with the BC Brain Wellness Program to test its MaxYield™ ECG technology in exercise settings for individuals with neurological conditions.
  • The initiative aims to capture and analyze cardiac data (HR/HRV) to explore potential biomarkers linking heart activity to brain health outcomes.
  • The pilot serves as a product verification phase that could pave the way for future research collaborations and expansion of MaxYield™ beyond cardiology into neurology and wellness domains.

Key Details

  • Partnership: AIML’s wholly‑owned subsidiary, Neural Cloud Solutions Inc., will work with the BC Brain Wellness Program (BCBWP).
  • Technology: MaxYield™ – an AI‑driven ECG signal‑enhancement engine that denoises and structures ECG data for reliable labeling and analysis.
  • Target Population: Participants with Parkinson’s disease, multiple sclerosis, stroke, and other chronic brain conditions, as well as care partners and healthy agers.
  • Pilot Scope: Supervised exercise sessions where wearable ECG devices collect real‑world cardiac data; focus on feasibility, utility, and identification of condition‑specific HR/HRV patterns.
  • Objectives:
  • Evaluate MaxYield’s performance in a neurology‑focused exercise environment.
  • Determine whether exercise‑induced cardiac responses correlate with neurological status and outcomes.
  • Identify potential HR/HRV biomarkers for future clinical research.
  • Quotes:
  • Dr. Silke Cresswell (Co‑Founder, BCBWP): Emphasized the importance of understanding heart‑brain interactions during exercise.
  • Esmat Naikyar (President, Neural Cloud Solutions & CPO, AIML): Highlighted the pilot as a step toward verifying algorithm performance in real‑world settings.
  • Paul Duffy (Executive Chairman & CEO, AIML): Stated the collaboration aligns with AIML’s strategy to expand MaxYield™ into neurology and wellness research.
  • Future Outlook: The data collected will inform subsequent research collaborations and may lead to new diagnostic or monitoring tools linking cardiac signals to neurological health.

Notable Quotes

“Our program is dedicated to exploring how exercise and lifestyle interventions can improve quality of life and outcomes for people living with neurological disorders… Partnering with AIML allows us to investigate the cardiac signals to better understand this bidirectional relationship.” – Dr. Silke Cresswell, Co‑Founder, BC Brain Wellness Program

“We are excited to explore how our platform can contribute to the growing understanding of the heart‑brain connection.” – Esmat Naikyar, President, Neural Cloud Solutions Inc. & Chief Product Officer, AIML

“This collaboration underscores our strategy to expand MaxYield™ beyond cardiology into adjacent domains such as neurology and wellness research.” – Paul Duffy, Executive Chairman & CEO, AI/ML Innovations Inc.

Read the original news release →

More from AI-ML Innovations Inc.